Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1KRegister to Unlock Ratings |
Performance History | 30/04/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -12.4 | 12.6 | -98.5 | 9.6 | 3.4 | |
+/-Cat | -3.3 | -5.4 | -96.5 | 1.4 | -2.1 | |
+/-B’mrk | - | - | - | 2.0 | -2.7 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
Closing Price 02/05/2024 | GBX 1117.60 | |
Day Change | 0.79% | |
Morningstar Category™ | UK Large-Cap Equity | |
Volume | 0 | |
Exchange | LONDON STOCK EXCHANGE, THE | |
ISIN | LU1437025296 | |
Fund Size (Mil) 02/05/2024 | EUR 148.23 | |
Share Class Size (Mil) 02/05/2024 | GBP 44.64 | |
Ongoing Charge 10/02/2023 | 0.18% |
Investment Objective: Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1K |
To track the performance of MSCI UK IMI SRI Filtered PAB Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Navarre Pierre 23/03/2022 | ||
Isabelle Lafargue 23/03/2022 | ||
Click here to see others | ||
Inception Date 13/12/2016 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI UK IMI filtered PAB NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1K | 29/04/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 5.51 |
RELX PLC | Industrials | 4.60 |
London Stock Exchange Group PLC | Financial Services | 4.52 |
Lloyds Banking Group PLC | Financial Services | 4.16 |
Reckitt Benckiser Group PLC | Consumer Defensive | 3.68 |
Increase Decrease New since last portfolio | ||
Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP (GBP) | FT1K |